Personalis Inc.
Company Snapshot
Company Overview
Personalis is a cancer genomics company that develops and commercializes advanced genomic testing services for oncology applications. Its tests support physicians in detecting residual or recurrent cancer, monitoring treatment response, and informing therapy selection. It also provides sequencing services to pharmaceutical companies and diagnostic partners for biomarker discovery, clinical trials, and the development of personalized cancer therapies.
In liquid biopsy, Personalis provides ultra-sensitive genomic tests designed to detect circulating tumor DNA for monitoring minimal residual disease and cancer recurrence. These tests support therapy response tracking and immunotherapy research. Personalis partners with leading cancer centers, research institutes, and pharmaceutical companies worldwide to gather clinical evidence for its technologies.
Financial Highlights (FY 2025)
This information is available for BCC Research members only.
Personalis Inc. In News
Company's Business Segments
- Pharma tests and services : Pharma tests and services includes Testing Services, Data Analytics for Clinical Trials, Research to Pharmaceutical Companies in support of their drug development programs.
- Enterprise sales : Enterprise sales includes Tumor Profiling, Diagnostic Tests directly to another business as an input to their products.
- Population sequencing : Population sequencing includes Genomic Sequencing Services, Data Analytics to support Large-scale Genetic Research Programs.
- Other : Other includes Genomic Tests, Analytics to universities and non-profits. This category also includes Diagnostics Tests ordered by healthcare providers for Cancer Patients.
Applications/End User Industries
- Healthcare
- Pharmaceutical
- Drug Development
- Data Analytics
- Biopharma
- Biotechnology
- Genomic Sequencing
- Tumor Profiling
- Genetic Research
- Tumor Sequencing and Analysis